Ingredients supplier ChromaDex will make its extensive ingredient library available to St. Jude for research.
St. Jude Children’s Research Hospital has forged a unique partnership with natural ingredients supplier ChromaDex (Irvine, CA) for children’s cancer research. ChromaDex will make its extensive ingredient library available to St. Jude, which will screen the library’s ingredients against biological assays and tumor models to identify ingredients that may have therapeutic promise-and that may be potentially patentable.
ChromaDex will also lend its expertise in natural products chemistry. St. Jude will perform further chemical assays to further characterize the natural compounds in the ChromaDex library.
“The ChromaDex catalog offers thousands of unique phytochemical compounds, many of which have never been investigated for their therapeutic potentials. We are excited to start this collaboration with St. Jude, as this program will not only allow ChromaDex to extract value from the natural products library, but also advance pediatric disease research,” said ChromaDex founder and CEO Frank Jaksch in a press release announcing the partnership.